CD302 and acute myeloid leukemia: Consequently, when conjugated with pyrrolobenzodiazepine (PBD) drugs, MMRI-20 effectively kills AML cell lines such as HL-60, while showing no toxicity toward hepatocytes (e.g., HepG2) that also express CD302.